Contineum Therapeutics, Inc Class A Common Stock
Price & Volume
Stats
See more52W Range | $8.60-$17.51 |
Market Cap | $648.9M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.72 |
News
See moreYahoo Finance • 30 days ago
Contineum Therapeutics Reports Second-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones
Yahoo Finance • 7 months ago
Cheap high flyer healthcare stocks - high momentum and low valuation
Yahoo Finance • 11 months ago
Contineum Therapeutics Reports Positive Topline Data From PIPE-791 Phase 1b PET Trial
Yahoo Finance • last year
Contineum Therapeutics Non-GAAP EPS of -$0.62
About
CEO | Mr. Carmine N. Stengone MBA, MS |
Address | 3565 General Atomics Court, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 51 |